FDA Fellowship - Elsa API integration and Development of Advanced User Interface
Oak Ridge Institute for Science and Education, Little Rock, AR, United States
How To Apply
An application
Transcripts – Click here for detailed information about acceptable transcripts
A current resume/CV, including academic history, employment history, relevant experiences, and publication list
One educational or professional recommendation
All documents must be in English or include an official English translation.
If you have questions, send an email to
ORISE.FDA.CDER@orau.org . Please include the reference code for this opportunity in your email.
Organization U.S. Food and Drug Administration (FDA)
Reference Code FDA-CDER-2026-0089
Application Deadline 5/8/2026 3:00:00 PM Eastern Time Zone
Description
Applications will be reviewed on a rolling basis.
FDA Office and Location A research opportunity is available immediately with the Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), National Center for Toxicological Research (NCTR), located in Jefferson, Arkansas.
Research Project The aim of this research focuses on integrating FDA’s GenAI tool’s capabilities (through API calls) into the InfoViP platform while developing an enhanced user interface that incorporates various functionalities to support adverse event analysis.
Learning Objectives
Understanding of pharmacovigilance data analysis workflows
Full-stack web-based application development
Integration of GenAI technologies into InfoViP platform
Mentor
Joshua Xu (Joshua.xu@fda.hhs.gov)
Leihong Wu (Leihong.Wu@fda.hhs.gov)
Oanh Dang (Oanh.Dang@fda.hhs.gov)
Appointment Details Anticipated Appointment Start Date:
March 2026, or earlier. Start date is flexible and will depend on a variety of factors.
Appointment Length:
The appointment will initially be for two years, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.
Level of Participation:
The appointment is full time.
Participant Stipend:
The participant will receive a monthly stipend commensurate with educational level and experience.
Citizenship Requirements This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.
Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA Ethics Requirements If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed at FDA. For additional requirements, see FDA Ethics for Nonemployee Scientists.
Education and Training Agreement FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
Non-employee nature of the ORISE appointment
Prohibition on ORISE Fellows performing inherently governmental functions
Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship
The fact that research materials and laboratory notebooks are the property of the FDA
ORISE fellow’s obligation to protect and not to further disclose or use non-public information
Qualifications
Degree: Master’s Degree or Doctoral Degree.
Discipline(s):
Computer, Information, and Data Sciences
Artificial Intelligence (including Robotics, Computer Vision, Human Language Processing, and Machine Learning)
Computer Architecture and Grids
Computer Science – Languages and Systems
Computer Science – Theoretical Foundations
Computer Science (general)
Computer Systems Analysis
Computer Systems Design (including Signal Processing)
Data Science
Databases, Information Retrieval, and Web Search
Graphics and Visualization
Human Computer Interaction
Information Science and Technology
Information Security and Assurance
Networks and Communications
Operating Systems and Middleware
Scientific Computing and Informatics
Software Engineering
Engineering
Life Health and Medical Sciences
Mathematics and Statistics
Affirmation: I am a U.S. citizen, or I have lived in the United States for at least 36 out of the past 60 months. I have read the FDA Ethics Requirements.
Point of Contact Ashley
#J-18808-Ljbffr
An application
Transcripts – Click here for detailed information about acceptable transcripts
A current resume/CV, including academic history, employment history, relevant experiences, and publication list
One educational or professional recommendation
All documents must be in English or include an official English translation.
If you have questions, send an email to
ORISE.FDA.CDER@orau.org . Please include the reference code for this opportunity in your email.
Organization U.S. Food and Drug Administration (FDA)
Reference Code FDA-CDER-2026-0089
Application Deadline 5/8/2026 3:00:00 PM Eastern Time Zone
Description
Applications will be reviewed on a rolling basis.
FDA Office and Location A research opportunity is available immediately with the Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), National Center for Toxicological Research (NCTR), located in Jefferson, Arkansas.
Research Project The aim of this research focuses on integrating FDA’s GenAI tool’s capabilities (through API calls) into the InfoViP platform while developing an enhanced user interface that incorporates various functionalities to support adverse event analysis.
Learning Objectives
Understanding of pharmacovigilance data analysis workflows
Full-stack web-based application development
Integration of GenAI technologies into InfoViP platform
Mentor
Joshua Xu (Joshua.xu@fda.hhs.gov)
Leihong Wu (Leihong.Wu@fda.hhs.gov)
Oanh Dang (Oanh.Dang@fda.hhs.gov)
Appointment Details Anticipated Appointment Start Date:
March 2026, or earlier. Start date is flexible and will depend on a variety of factors.
Appointment Length:
The appointment will initially be for two years, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.
Level of Participation:
The appointment is full time.
Participant Stipend:
The participant will receive a monthly stipend commensurate with educational level and experience.
Citizenship Requirements This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.
Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA Ethics Requirements If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed at FDA. For additional requirements, see FDA Ethics for Nonemployee Scientists.
Education and Training Agreement FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
Non-employee nature of the ORISE appointment
Prohibition on ORISE Fellows performing inherently governmental functions
Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship
The fact that research materials and laboratory notebooks are the property of the FDA
ORISE fellow’s obligation to protect and not to further disclose or use non-public information
Qualifications
Degree: Master’s Degree or Doctoral Degree.
Discipline(s):
Computer, Information, and Data Sciences
Artificial Intelligence (including Robotics, Computer Vision, Human Language Processing, and Machine Learning)
Computer Architecture and Grids
Computer Science – Languages and Systems
Computer Science – Theoretical Foundations
Computer Science (general)
Computer Systems Analysis
Computer Systems Design (including Signal Processing)
Data Science
Databases, Information Retrieval, and Web Search
Graphics and Visualization
Human Computer Interaction
Information Science and Technology
Information Security and Assurance
Networks and Communications
Operating Systems and Middleware
Scientific Computing and Informatics
Software Engineering
Engineering
Life Health and Medical Sciences
Mathematics and Statistics
Affirmation: I am a U.S. citizen, or I have lived in the United States for at least 36 out of the past 60 months. I have read the FDA Ethics Requirements.
Point of Contact Ashley
#J-18808-Ljbffr